CHP1 reduction ameliorates spinal muscular atrophy pathology by restoring calcineurin activity and endocytosis.
Page 1 of 1
CHP1 reduction ameliorates spinal muscular atrophy pathology by restoring calcineurin activity and endocytosis.
Jon Moulton Fri Aug 10, 2018 11:42 am
Janzen E, Mendoza-Ferreira N, Hosseinibarkooie S, Schneider S, Hupperich K, Tschanz T, Grysko V, Riessland M, Hammerschmidt M, Rigo F, Bennett CF, Kye MJ, Torres-Benito L, Wirth B. CHP1 reduction ameliorates spinal muscular atrophy pathology by restoring calcineurin activity and endocytosis. Brain. 2018 Jun 28. doi: 10.1093/brain/awy167. [Epub ahead of print]
Jon Moulton- Posts : 5721
Join date : 2010-03-12
Age : 62
Location : Philomath, Oregon, USA -
Similar topics» Neurocalcin Delta Suppression Protects against Spinal Muscular Atrophy in Humans and across Species by Restoring Impaired Endocytosis
» Systemic restoration of UBA1 ameliorates disease in spinal muscular atrophy
» The Power of Human Protective Modifiers: PLS3 and CORO1C Unravel Impaired Endocytosis in Spinal Muscular Atrophy and Rescue SMA Phenotype
» Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy
» Electrophysiological Biomarkers in Spinal Muscular Atrophy: Preclinical Proof of Concept
» Systemic restoration of UBA1 ameliorates disease in spinal muscular atrophy
» The Power of Human Protective Modifiers: PLS3 and CORO1C Unravel Impaired Endocytosis in Spinal Muscular Atrophy and Rescue SMA Phenotype
» Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy
» Electrophysiological Biomarkers in Spinal Muscular Atrophy: Preclinical Proof of Concept
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum